FDA
-
-
-
-
-
-
-
Ardelyx (ARDX) Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities
-
-
-
-
-
-
-
Ardelyx (ARDX) Announces XPHOZAH now Available in the US
-
-
-
-
-
-
-
Ardelyx (ARDX) 30-day option implied volatility into action date
-
-
-
-
-
-
-
Ardelyx (ARDX) call put ratio 4.1 calls to 1 put into FDA action date
-
-
-
-
-
-
-
H.C. Wainwright Starts Ardelyx, Inc (ARDX) at Buy 'Ahead of the potential approval of XPHOZAH next quarter'
-
-
-
-
-
-
-
Ardelyx (ARDX) Resubmits New Drug Application to U.S. Food and Drug Administration for XPHOZAH (tenapanor)
-
-
-
-
-
-
-
FDA Grants Appeal for Ardelyx's XPHOZAH® (tenapanor)
-
258,211 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All